新闻与博客

欢迎访问 Atelerix 新闻与博客——这里将以温暖的视角探讨如何在不依赖低温的情况下让细胞保持活力,并分享公司动态与研究见解(无需担心冻伤)。

NEWS HOG 正文

精选文章

从实验室到市场:类器官技术的最新进展与商业化

2025年8月24日

作者:索菲·雷伊 类器官是由干细胞衍生的三维(3D)组织培养物,它们能够自发组装成与[…]极为相似的结构

苏尼尔·沙阿(Sunil Shah)和凯瑟琳·埃尔顿博士(Dr Catherine Elton)加入Atelerix董事会,以推动全球业务扩张

2025年8月12日

苏尼尔·沙阿(Sunil Shah)和凯瑟琳·埃尔顿博士(Dr Catherine Elton)加入Atelerix董事会,共同推动全球业务扩张 行业领军人物苏尼尔·沙阿(o2h首席执行官[…]

两年后:基于海藻酸盐的给药方式使干细胞疗法带来持久的视力改善

2025年5月21日

在 Atelerix,我们很自豪能支持那些将创新科学转化为实际患者获益的开创性工作。最近的一项临床里程碑 […]

Cryologistics: Science’s Carbon-Intensive Secret

六月 28, 2024

In the pursuit of ground-breaking discoveries and life-changing innovations, the scientific community has long relied on a crucial yet often […]

Atelerix Teams Up with North Star Scientific to Revolutionise Life Sciences in North America

六月 26, 2024

Crafting a Future Beyond Cryopreservation – One Hedgehog at a Time  Newcastle, UK – 星期三 26th 六月 2024 –   Atelerix, the […]

New White Paper Released!

五月 10, 2024

The use of organoids for disease modelling, drug discovery and personalised medicine has become increasingly popular. Processes for the generation […]

Storage of cancer tissue at room temperature using TissueReady™ PLUS

五月 10, 2024

New White Paper Released! The sourcing of primary tissue is vital for many fields of research and is becoming increasingly […]

Atelerix work with RareCan, NovoPath and the Rare Cancer Research Group

四月 18, 2024

Freshly obtained clinical tissue is used for several purposes including advanced diagnostic techniques, basic research and establishing physiologically relevant models for […]

New distributor agreement between Atelerix (UK) and Scintila S.R.O (Czech Republic and Slovakia).

四月 18, 2024

We are proud to announce the beginning of a new distribution agreement with Scintila S.R.O, who will be distributing our […]

GBIP Canada Application Success

三月 29, 2024

Atelerix has been awarded a place on the Global Business Innovation Programme for Biomanufacturing of Biologics and Advanced Therapies in […]

Press Release: Strategic partnership for market expansion

三月 27, 2024

Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells, tissues, and viruses at hypothermic […]

New Publication Announcement!

三月 17, 2024

Following on from LVPEI’s successful proof of concept studies highlighting the successful use of Atelerix’s technology to distribute a limbal-stromal cell therapy throughout […]

BeadReady™ successfully storing cells for 3D biofabrication – Read our latest publication

三月 10, 2024

Another fantastic publication highlighting one of the multiple applications Atelerix products have within the scientific research and development industry. Anastassia […]

CytoStor™ successfully preserves primary human Liver Sinusoidal Endothelial cells (LSEC)

二月 29, 2024

The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The […]

New Publication Announcement!

一月 29, 2024

Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived […]

CytoStor™ & the transport of precious cells

十一月 29, 2023

How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic […]

TissueReady™ & Organoid Modelling

十月 26, 2023

Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the […]

Atelerix supports lifetime CDT

十月 19, 2023

The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership […]

购物车
返回顶部